Parenteral formulation V: development of analytical methods for a sterile product
Mollica, J.A.; Lin, K.S.
Bulletin of the Parenteral Drug Association 25(3): 140-148
1971
ISSN/ISBN: 0048-2986 PMID: 5093250 Document Number: 32155
Document emailed within 1 workday
Related Documents
Chilamkurti, R.N. 1992: Formulation development of frozen parenteral dosage forms Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(4): 124-129Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Anschel, J.; Mollica, J.A.; Lin, K.S. 1972: Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions Bulletin of the Parenteral Drug Association 26(6): 271-289
Frieben, W.R.; Enzinger, R.M. 1992: Sterile product manufacturing technology Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(3): 85-86
Ortiz, M.C.; Sarabia, L.A.; Sánchez, M.S. 2023: The inversion of multiresponse partial least squares models, a useful tool to improve analytical methods in the framework of analytical quality by design Analytica Chimica Acta 1276: 341620
Romano, J.W.; Van Damme, L.; Hillier, S. 2014: The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development Bjog: An International Journal of Obstetrics and Gynaecology 121 Suppl. 5: 15-18
Hirst, C. 1980: Topical steroid preparations. the relationship between the clinical use and the formulation of the product base Australian Family Physician 9(11): 816-819
Beijnen, J.H.; van Gijn, R.; Challa, E.E.; Kaijser, G.P.; Underberg, W.J. 1992: Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 46(4): 111-116
Ames, M.M.; Richardson, R.L.; Kovach, J.S.; Moertel, C.G.; O'Connell, M.J. 1990: Phase i and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation Cancer Research 50(1): 206-210
Syverson, J.A. 1972: Master and batch records in parenteral product manufacture Bulletin of the Parenteral Drug Association 26(5): 239-246
Jürgens, K.; Müller, B.W. 2005: A new formulation concept for drugs with poor water solubility for parenteral application Die Pharmazie 60(9): 665-670
Ronchi, C.; Burinato, C.; Zanol, M.; Borsa, M. 1986: Optimization of a formulation for parenteral use containing a thermolabile drug, and evaluation of possible steam sterilization Bollettino Chimico Farmaceutico 125(4): 93-99
Macias, J.M.; Martin, W.J.; Lloyd, C.W. 1985: Stability of morphine sulfate and meperidine hydrochloride in a parenteral nutrient formulation American Journal of Hospital Pharmacy 42(5): 1087-1094
Berger, T.J.; Nelson, P.A. 1995: The effect of formulation of parenteral solutions on microbial growth--measurement of D- and z-values PDA Journal of Pharmaceutical Science and Technology 49(1): 32-41
Sacks, G.S.; Mir, T.L.; Lee, M. 1999: Skin necrosis induced by extravasation of glycerol-containing peripheral parenteral nutrition formulation Journal of the Mississippi State Medical Association 40(9): 307-311
Ayanoglu, G.; Witte, P.U.; Badian, M. 1983: Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil) International Journal of Clinical Pharmacology Therapy and Toxicology 21(9): 479-482
Buogo, A.; Ratti, L. 1972: Methods for the microbiological control of non sterile drugs Il Farmaco; Edizione Pratica 27(9): 523-531
Del Rosso, J.Q.; Kircik, L.H. 2014: Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream Journal of Drugs in Dermatology: Jdd 13(7): S77-S83
Panteloglou, A. 1993: Packing and sterilization methods for disposable sterile medical devices Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S564-S565
Weber, E.; Bilzer, W. 1973: Analytical methods Arzneimittel-Forschung 23(11 Suppl): 1631-1634